paclitaxel has been researched along with Diathesis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Alberti, P; Ballarini, E; Canta, A; Cavaletti, G; Chiorazzi, A; Fumagalli, G; Guarnieri, C; Marmiroli, P; Meregalli, C; Monza, L; Oggioni, N; Pozzi, E; Rodriguez-Menendez, V; Scali, C | 1 |
Burbujo, J; Calderón-Komaromy, A; Córdoba, S; de Pablo, NP; Freites-Martínez, A; Martinez-Sánchez, D | 1 |
Jones, HR; Srinivasan, J | 1 |
Aranda Aguilar, E; de la Haba-Rodríguez, JR; Gómez-España, MA; Ortiz-Morales, MJ | 1 |
4 other study(ies) available for paclitaxel and Diathesis
Article | Year |
---|---|
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Axons; Biomarkers; Disease Models, Animal; Disease Susceptibility; Humans; Hyperalgesia; Immunoglobulins, Intravenous; Macrophages; Neurotoxicity Syndromes; Paclitaxel; Peripheral Nervous System Diseases; Rats; Treatment Outcome | 2021 |
[Exudative onycholysis and acute bacterial paronychia related to BIBF-1120 and paclitaxel: response to topical therapy].
Topics: Angiogenesis Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Disease Susceptibility; Female; Fusidic Acid; Hand; Humans; Indoles; Methylprednisolone; Middle Aged; Onycholysis; Paclitaxel; Paronychia; Staphylococcal Skin Infections | 2014 |
Sensory polyneuropathy associated with paclitaxel-eluting coronary stent.
Topics: Aged; Angina, Unstable; Angioplasty, Balloon; Coronary Restenosis; Disease Susceptibility; Drug-Eluting Stents; Humans; Male; Neural Conduction; Paclitaxel; Paresthesia; Polyneuropathies; Recurrence; Sensation Disorders; Sjogren's Syndrome | 2009 |
[ABCB1 polymorphisms in patients with Charcot-Marie-Tooth disease. A possible relationship with neurotoxicity due to cytostatic treatment].
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Charcot-Marie-Tooth Disease; Colonic Neoplasms; Cytostatic Agents; Disease Susceptibility; Female; Genotype; Humans; Multidrug Resistance-Associated Proteins; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide | 2012 |